License Required
Menveo® Meningitis Vaccine Indicated for People 10 Years Through 55 Years of Age Meningococcal (Groups A, C, Y AND W-135) Oligosaccharide Diphtheria CRM197 Conjugate Vaccine 10 mcg - 5 mcg / 0.5 mL Injection Single-Dose Vial 0.5 mL
58160082730 | USAMP#67317086
container type
volume
dosage form
strength
Secure Checkout
Verified Supply Chain
Priority Fulfillment
Locked
Base Price
$2,223.29
CT
🎯 Unlock Your Custom Tiered Price
15-35% bulk discounts
100+
units
10% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
250+
units
20% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
500+
units
30% OFF
$XX.XX
per unit
Save $XXX
Payment Terms
Priority Shipping
Custom Contract Pricing
Unlock Bulk Pricing
See pricing for all volume tiers
Instant access to volume pricing. Register free to compare all tiers and calculate your exact savings.
5,000+ verified buyers
Average savings:$23,400/year
15-35% OFF
for healthcare facilities on bulk orders
24/7 Live Chat!
Instant support anytime
Product Spotlight
- MENVEO is a vaccine indicated for active immunization to prevent invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135
- MENVEO does not prevent N. meningitidis serogroup B infections
- Single-vial presentation
